Mycobacterium lentiflavum, an emerging pathogen?

J Infect. 2006 Jun;52(6):e185-7. doi: 10.1016/j.jinf.2005.08.020. Epub 2005 Oct 11.

Abstract

Three cases of infection due to Mycobacterium lentiflavum, a recently described species characterized by multiple resistance to anti-mycobacterial drugs, are reported here. While one case simply adds to the number of cervical lynphadenitis reported in literature, the others concern the first isolations from pleural effusions, in a young boy with leukaemia and in an elderly patient with lung disease, respectively.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Aged, 80 and over
  • Anti-Bacterial Agents / administration & dosage
  • Communicable Diseases, Emerging / drug therapy
  • Communicable Diseases, Emerging / microbiology*
  • Humans
  • Immunocompromised Host
  • Infant
  • Leukemia / complications*
  • Lymphadenitis / microbiology*
  • Male
  • Mycobacterium / classification
  • Mycobacterium / isolation & purification
  • Mycobacterium / pathogenicity*
  • Mycobacterium Infections / complications
  • Mycobacterium Infections / drug therapy
  • Mycobacterium Infections / microbiology*
  • Pleura / microbiology
  • Pleural Effusion / etiology
  • Pleural Effusion / microbiology
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents